BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models.Ye Liu,Jing Li,Zhuo Li, Qin Wang,Xing Zhou,Xiaoxin Liu, Bo Zhang, Xitao Wang,Sanjia Xu,Hanzi Sun,Xiaomin Song,Xi Yuan,Zhiwei Wang,Xuesong LiuCANCER RESEARCH(2022)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要